Centre Muraz: Clinical Trials

7 trials sponsored by Centre Muraz, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 unknown. 7 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 6, Unknown 1
Phase 23Completed 2, Unknown 1

Follow Centre Muraz: new trials by email

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection
Nitazoxanide and Ciclésonide, Telmisartan 20Mg Oral Tablet, Paracetamol - Covid19, Covid19 Drug Treatment
Phase 2 / Phase 3UnknownANRS, Emerging Infectious Diseases6002021-04-122023-01-31
Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention
Lamivudine Oral Solution - HIV-1
Phase 3CompletedANRS, Emerging Infectious Diseases15062019-12-142022-12-07
Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study
Ivermectin, Albendazole - Malaria, Lymphatic Filariasis
Phase 2 / Phase 3CompletedColorado State University27122015-06-012019-01-04
Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated Malaria
Artemether/Lumefantrine, Artesunate/Amodiaquine, Quinine + Clindamycin - Malaria
Phase 3CompletedUniversiteit Antwerpen21172012-05-012014-10-22
Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria
Dihydroartemisinin-piperaquine, Artesunate-mefloquine, Artesunate-amodiaquine - Malaria in Pregnancy
Phase 3CompletedInstitute of Tropical Medicine, Belgium34282010-06-012016-03-14
Pharmacokinetic of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnancy
Mefloquine-artesunate - Plasmodium Falciparum Malaria
Phase 2 / Phase 3CompletedInstitute of Tropical Medicine, Belgium482008-10-012010-09-14
Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children
amodiaquine-artesunate (ASAQ), dihydroartemisinin-piperaquine (DHAPQ), artemether-lumefantrine (AL) - Fever, Malaria
Phase 3CompletedInstitute of Tropical Medicine, Belgium41122007-07-012014-02-03

Conditions studied

Malaria (4)  ·  COVID-19 (1)  ·  Elephantiasis, Filarial (1)  ·  Fever (1)  ·  Malaria, Falciparum (1)

Interventions

Artemether, Lumefantrine Drug Combination (3)  ·  amodiaquine, artesunate drug combination (3)  ·  Acetaminophen (1)  ·  Albendazole (1)  ·  Artesunate (1)  ·  Clindamycin (1)  ·  Fluoxetine (1)  ·  Ivermectin (1)  ·  Lamivudine (1)  ·  Quinine (1)  ·  Tablets (1)  ·  Telmisartan (1)  ·  chloroguanil, dapsone drug combination (1)  ·  nitazoxanide (1)

Countries

Burkina Faso (6)  ·  Zambia (3)  ·  Uganda (2)  ·  Gabon (1)  ·  Ghana (1)  ·  Guinea (1)  ·  Malawi (1)  ·  Mozambique (1)  ·  Nigeria (1)  ·  Republic of the Congo (1)  ·  Rwanda (1)  ·  United States (1)

Top investigators

Umberto D'Alessandro, MD (2)  ·  Brian D. Foy, PhD (1)  ·  Carolyn Nabasumba, M.B.Ch.B (1)  ·  Hypolite M. Mavoko, MD MPH (1)  ·  Philippe Van de Perre, MD, PhD (1)  ·  Roch K Dabire, PhD (1)  ·  Tinto Halidou, PhD (1)  ·  Tinto Halidou, PharmD (1)  ·  UmbertoC D'Alessandro, MD MsC PhD (1)

Results publications

PMID 22087077, PMID 24059911, PMID 24891429, PMID 25592254, PMID 26088768, PMID 26962727, PMID 27280792, PMID 27840069, PMID 27895848, PMID 30878222, PMID 30922317, PMID 32025570, PMID 34627141, PMID 36574985, PMID 38484756